Abstract: A method of treating or preventing high-risk plaque is provided. The method may include applying to a medical device an effective amount of a composition comprising a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof. The medical device may be inserted into an area of a living organism that is or has a propensity to be affected by high-risk plaque.
Type:
Application
Filed:
September 12, 2003
Publication date:
July 1, 2004
Applicant:
Estrogen Vascular Technology, LLC
Inventors:
Gishel New, Jeffrey W. Moses, Nicholas Kipshidze, Gary S. Roubin, Martin B. Leon
Abstract: A method of treating or preventing vascular disease in a living organism. The method includes delivering an effective amount of a composition including a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof, to an affected area of a living organism.
Type:
Application
Filed:
September 30, 2002
Publication date:
February 27, 2003
Applicant:
ESTROGEN VASCULAR TECHNOLOGY, LLC.
Inventors:
Gishel New, Jeffrey W. Moses, Nicholas Kipshidze, Gary S. Roubin, Martin B. Leon
Abstract: A method of treating or preventing vascular disease in a living organism. The method includes delivering an effective amount of a composition including a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof, to an affected area of a living organism.
Type:
Grant
Filed:
August 30, 2001
Date of Patent:
October 29, 2002
Assignee:
Estrogen Vascular Technology, LLC
Inventors:
Gishel New, Jeffrey W. Moses, Nicholas Kipshidze, Gary S. Roubin, Martin B. Leon